TEVA: 梯瓦制药
今日TEVA汇率已更改1.16%。当日,交易品种以低点30.72和高点31.53进行交易。
关注梯瓦制药动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TEVA新闻
- Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio – Q1 2026 Update
- I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade) (NYSE:JNJ)
- J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
- Organon & Co: Great Odds, Small Prize, Big Penalty (NYSE:OGN)
- Is JNJ Stock a Buy, Sell or Hold Ahead of Q2 Earnings Release?
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b - Slideshow (NYSE:TEVA) 2026-07-09
- Strength Seen in Supernus (SUPN): Can Its 5.2% Jump Turn into More Strength?
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b Transcript
- Teva Pharmaceutical's Innovative Shift Continues With Ecopipam Addition (NYSE:TEVA)
- Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study
- Teva's Shift Beyond Generics Puts Focus on Branded Drug Growth
- 3 Best Healthcare Stocks to Buy in June, According to Analysts - TipRanks.com
- Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome
- J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?
- Canada’s Apotex Health Expected to Price IPO at Top End of Range - TipRanks.com
- Is Amneal a Buy Before Rytary Generic Erosion?
- Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come (NYSE:EBS)
- Teva Pharmaceutical Industries Limited (TEVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
- 3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
- Can JNJ Sustain Growth Amid Patent, Legal and China Risks?
- AbbVie Gets EU Nod for Aquipta as Acute Treatment for Migraine
常见问题解答
TEVA股票今天的价格是多少?
梯瓦制药股票今天的定价为31.36。它在30.72 - 31.53范围内交易,昨天的收盘价为31.00,交易量达到7353。TEVA的实时价格图表显示了这些更新。
梯瓦制药股票是否支付股息?
梯瓦制药目前的价值为31.36。股息政策取决于公司,而投资者也会关注64.15%和USD。实时查看图表以跟踪TEVA走势。
如何购买TEVA股票?
您可以以31.36的当前价格购买梯瓦制药股票。订单通常设置在31.36或31.66附近,而7353和0.74%显示市场活动。立即关注TEVA的实时图表更新。
如何投资TEVA股票?
投资梯瓦制药需要考虑年度范围19.01 - 37.34和当前价格31.36。许多人在以31.36或31.66下订单之前,会比较-7.52%和。实时查看TEVA价格图表,了解每日变化。
梯瓦制药股票的最高价格是多少?
在过去一年中,梯瓦制药的最高价格是37.34。在19.01 - 37.34内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪梯瓦制药的绩效。
梯瓦制药股票的最低价格是多少?
梯瓦制药(TEVA)的最低价格为19.01。将其与当前的31.36和19.01 - 37.34进行比较,可以发现潜在的长期切入点。观看TEVA在图表上的实时走势以获取更多详细信息。
TEVA股票是什么时候拆分的?
梯瓦制药历史上曾经历过股票拆分。这些变化在公司行动后的、31.00和64.15%中可见。
- 前一天收盘价
- 31.00
- 开盘价
- 31.13
- 卖价
- 31.36
- 买价
- 31.66
- 最低价
- 30.72
- 最高价
- 31.53
- 交易量
- 7.353 K
- 日变化
- 1.16%
- 月变化
- -7.52%
- 6个月变化
- -9.13%
- 年变化
- 64.15%
- 实际值
- 预测值
- 1.978 M
- 前值
- -1.692 M
- 实际值
- 预测值
- 0.992 M
- 前值
- 0.430 M
- 实际值
- 预测值
- 前值
- 4.927%